Markel: Still Undervalued While Insurance Performance Is Set To Improve

I have a long-term "strong buy" rating on Markel (NYSE: MKL ) based on attractive valuation and their strong culture. The "Berkshire-like" model acquires new relevance as the OG steps down. Specialty insurance is hard to disrupt, and there is a Striving to compound knowledge. Long-time fan of Warren and Charlie. Always invert. "To finish first, you must first finish". Investing own and family funds for +20 years. Senior finance roles at public and private corporations for most of that time. Analyst's Disclo ...